Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy.
Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany.
Arslan Arinc
AA
Kayacelebi
Department of Cardiology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia.
Thanh Ha
TH
Nguyen
Department of Cardiology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia.
Chris
C
Neil
Department of Cardiology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia.
John D
JD
Horowitz
Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany.
Jens
J
Jordan
Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. Electronic address: tsikas.dimitros@mh-hannover.de.
Dimitrios
D
Tsikas
D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D005260:Female; D006709:Homoarginine / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D054549:Takotsubo Cardiomyopathy / Q000097:blood* / Q000175:diagnosis*; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000097:blood
D015415:Biomarkers; D006709:Homoarginine; C002744:3-nitrotyrosine; D014443:Tyrosine
Homoarginine; Nitric oxide; Nitrotyrosine; Takotsubo